Keyphrases
Chronic Hepatitis C
100%
Primary Biliary Cholangitis
74%
COVID-19
61%
Transient Elastography
60%
Fibrosis
50%
Liver Stiffness
49%
Liver Fibrosis
46%
Primary Biliary Cirrhosis
45%
Autoimmune Hepatitis
35%
Ursodeoxycholic Acid
33%
Liver Transplantation
31%
Liver Biopsy
30%
Cirrhosis
29%
Hepatocellular Carcinoma
28%
Chronic Liver Disease
24%
Systemic Sclerosis
22%
Alcoholic Liver Disease
20%
Liver Transplant Recipients
20%
Liver
19%
Vibration-controlled Transient Elastography
19%
Hepatitis C Virus
18%
Hepatic Iron Content
17%
Cytochrome P450 2E1 (CYP2E1)
17%
Autoantibodies
17%
Growth Arrest-specific Gene 6 (Gas6)
17%
Spleen
17%
Liver Disease
16%
Working Diagnosis
15%
Risk Factors
15%
Bilirubin
14%
Clinical Course
14%
Prognostic Model
13%
Direct-acting Antivirals
13%
Steatosis
13%
Spleen Stiffness Measurement
12%
Antibody-associated
12%
Oxidative Stress
12%
Hepatitis C Virus Infection
11%
Inflammation
11%
Chronic Autoimmune Diseases
11%
Upper Normal Limit
11%
Odds Ratio
11%
Ascites
11%
Genome-wide Meta-analysis
11%
Antiphospholipid Antibodies
11%
Mycophenolate
11%
Infected Patients
11%
Etiology
11%
Albumin
11%
Immunocompromised Patients
10%
Medicine and Dentistry
Primary Biliary Cirrhosis
91%
Transient Elastography
82%
Fibrosis
61%
Liver Fibrosis
46%
COVID-19
36%
Chronic Hepatitis C
34%
Liver Transplantation
33%
Liver Biopsy
32%
Hepatitis C
30%
Autoimmune Hepatitis
28%
Chronic Liver Disease
24%
Liver Cirrhosis
23%
Ursodeoxycholic Acid
22%
Hepatocellular Carcinoma
22%
Alkaline Phosphatase
18%
Reproducibility
17%
Systemic Scleroderma
17%
Hepatitis C Virus
15%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Disease Course
14%
Antiviral Drug
14%
Bilirubin
13%
Chronic Viral Hepatitis
13%
Cholestasis
13%
Iron
12%
Liver Disease
12%
Antiviral Therapy
11%
Infection
11%
Diseases
11%
Fatty Liver
11%
Sequela
11%
Ascites
11%
Growth Disorder
11%
Esophageal Varices
11%
Portal Hypertension
10%
Receptor
10%
Graft Dysfunction
9%
Liver Graft
9%
Biological Marker
8%
Peripheral Edema
8%
Steatosis
8%
FibroScan
8%
Cohort Analysis
8%
Chronic Hepatitis
8%
Immunotherapy
7%
Alcohol Consumption
7%
Liver Injury
7%
Patient Referral
7%
Hazard Ratio
7%
Recurrent Disease
7%
Pharmacology, Toxicology and Pharmaceutical Science
Primary Biliary Cirrhosis
63%
Diseases
56%
Fibrosis
46%
Chronic Hepatitis C
46%
Liver Fibrosis
39%
Coronavirinae
39%
Iron
30%
Hepatitis C
29%
Liver Cirrhosis
28%
Autoimmune Hepatitis
28%
Ursodeoxycholic Acid
27%
Cohort Study
25%
SARS Coronavirus
22%
Systemic Sclerosis
22%
Liver Cell Carcinoma
22%
Antiviral Drug
18%
Hepatitis C Virus
18%
Growth Disorder
17%
Receptor
16%
Bilirubin
15%
Disease Course
15%
Alkaline Phosphatase
13%
Infection
13%
Antivirus Agent
13%
Inflammation
11%
Chronic Liver Disease
10%
Albumin
10%
Liver Injury
9%
Fatty Liver
9%
Immunosuppressive Agent
8%
Steatosis
7%
Biological Marker
7%
Clinical Feature
7%
Chronic Hepatitis
7%
Case Fatality Rate
7%
Liver Disease
6%
Tacrolimus
6%
Diabetes Mellitus
6%
Malonaldehyde
6%
4 Hydroxynonenal
6%
Alcohol Liver Disease
6%
Autoimmune Disease
6%
COVID-19 Vaccine
6%
Immunotherapy
5%
Viral Clearance
5%
Hospital Mortality
5%
Sofosbuvir
5%
Peripheral Edema
5%
Ciclosporin
5%
Chronic Hepatitis B
5%
